Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.14-3.38%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 891.92M | 881.45M | 883.93M | 900.13M | 931.56M |
| Total Other Revenue | 17.84M | 19.03M | 17.84M | 17.84M | 13.05M |
| Total Revenue | 909.76M | 900.49M | 901.77M | 917.97M | 944.61M |
| Cost of Revenue | 668.68M | 638.52M | 612.74M | 606.04M | 592.40M |
| Gross Profit | 241.08M | 261.97M | 289.03M | 311.93M | 352.21M |
| SG&A Expenses | 133.02M | 131.91M | 135.81M | 135.39M | 128.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -147.20K | 2.46M | 338.20K | 78.30K | 1.26M |
| Total Operating Expenses | 837.25M | 806.24M | 781.24M | 774.64M | 755.64M |
| Operating Income | 72.51M | 94.24M | 120.53M | 143.33M | 188.97M |
| Income Before Tax | 111.35M | 57.81M | 61.71M | 92.43M | 175.29M |
| Income Tax Expenses | 22.72M | 22.74M | 27.78M | 30.09M | 32.74M |
| Earnings from Continuing Operations | 88.63 | 35.06 | 33.93 | 62.35 | 142.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.49M | 5.84M | 12.44M | -5.98M | -9.31M |
| Net Income | 85.13M | 40.90M | 46.37M | 56.36M | 133.24M |
| EBIT | 72.51M | 94.24M | 120.53M | 143.33M | 188.97M |
| EBITDA | 101.09M | 122.12M | 148.16M | 170.36M | 215.27M |
| EPS Basic | 0.10 | 0.05 | 0.05 | 0.06 | 0.15 |
| Normalized Basic EPS | 0.09 | 0.10 | 0.11 | 0.11 | 0.16 |
| EPS Diluted | 0.10 | 0.05 | 0.05 | 0.06 | 0.15 |
| Normalized Diluted EPS | 0.09 | 0.10 | 0.11 | 0.11 | 0.16 |
| Average Basic Shares Outstanding | 3.43B | 3.43B | 3.45B | 3.45B | 3.46B |
| Average Diluted Shares Outstanding | 3.43B | 3.43B | 3.45B | 3.45B | 3.46B |
| Dividend Per Share | 0.04 | 0.04 | 0.04 | 0.04 | 0.08 |
| Payout Ratio | 60.94% | 289.09% | 192.19% | 158.99% | 65.76% |